Efficacy of dexmedetomidine- bupivacaine versus nalbuphine-bupivacaine in ultrasound-guided deep serratus anterior plane block on the quality of recovery following modified radical mastectomy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202408744793714

Enrollment

Registered

2024-08-15

Start date

2023-12-30

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Surgery Anaesthesia

Interventions

injection

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female gender scheduled for unilateral MRM -ASA :I-II Age: 20-60 y

Exclusion criteria

Exclusion criteria: patient refusal to participate in the study -BMI>40kg/m2 -infection at site of needle insertion -hypersensitivity to the studied drugs -psychotic disorders -Bilateral MRM -bleeding disorders -chronic renal hepatic disease

Design outcomes

Primary

Measure	Time frame
Quality of recovery as physical and mental well-being according to quality of recovery -15	—

Secondary

Measure	Time frame
VAS visual analogue scale scored from 0-10( where 0=no pain) and 10 = the worst pain imaginable	—

Countries

Egypt

Contacts

Public Contactehab mokbel

lecturer

salmaelsayed84@mans.edu.eg+201002990553

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026